PMVP vs. MO

In the year-to-date period, PMVP achieves a -40.70% return, which is significantly lower than MO's 15.80% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PMVP Sharpe Ratio is -1.11, which is lower than the MO Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of PMVP and MO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PMVP has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 6.79%.

The maximum PMVP drawdown since its inception was -98.64%, which is greater than MO's maximum drawdown of -57.39%. Use the drawdown chart below to compare losses from any high point for PMVP and MO.

PMV Pharmaceuticals, Inc. (PMVP) has a higher volatility of 13.20% compared to Altria Group, Inc. (MO) at 6.37%. This indicates that PMVP's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between PMV Pharmaceuticals, Inc. and Altria Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.